Showing results (1631-1640 of 5,060) with videos related to

Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|February 18, 2020
Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest FinlandLaura Airas, Marjo Nylund, Iina Mannonen, et al.
Multiple Sclerosis and Related Disorders|February 9, 2020
Diet quality is not associated with late-onset multiple sclerosis risk- A Danish Cohort StudyUwe M Pommerich, Rasmus Østergaard Nielsen, Kim Overvad, et al.
Multiple Sclerosis and Related Disorders|February 10, 2020
Neuromyelitis optica spectrum disorder coexisting with ankylosing spondylitis: A case reportJingfang Lin, Jie Zhang, Xu Liu, et al.
Multiple Sclerosis and Related Disorders|November 10, 2019
The prevalence and types of oral- and pharyngeal-stage dysphagia in patients with demyelinating diseases based on subjective assessment by the study subjectsMagdalena Milewska, Katarzyna Grabarczyk, Marta Dąbrowska-Bender, et al.
Multiple Sclerosis and Related Disorders|December 9, 2019
The clinical value of the albumin quotient in patients with neuromyelitis optica spectrum disorderBo Chen, Chuan Qin, Ran Tao, et al.
Multiple Sclerosis and Related Disorders|December 9, 2019
Cesarean section in women with MS: A choice or a need?De Giglio L, Federici S, Ruggieri S, et al.
Multiple Sclerosis and Related Disorders|January 10, 2020
Assessing life balance of European people with multiple sclerosis: A multicenter clinimetric study within the RIMS networkDaphne Kos, Sofie Ferdinand, Marijke Duportail, et al.
Multiple Sclerosis and Related Disorders|January 12, 2020
Comparison of the effects of two different exergaming systems on balance, functionality, fatigue, and quality of life in people with multiple sclerosis: A randomized controlled trialYonca Zenginler Yazgan, Ela Tarakci, Devrim Tarakci, et al.
Multiple Sclerosis and Related Disorders|March 11, 2020
Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseasesJ Rigal, J Ciron, Z Lépine, et al.
Multiple Sclerosis and Related Disorders|February 21, 2020
Matching-adjusted comparisons demonstrate better clinical outcomes in patients with relapsing multiple sclerosis treated with peginterferon beta-1a than with teriflunomideScott D Newsome, Oksana Mokliatchouk, Carmen Castrillo-Viguera, et al.
Pageof 506